2 min read

Medable is The Leader in DCTs

Aug 4, 2021 1:03:03 PM

On Friday, July 16 2021, we were honored to learn that The Everest Group named Medable as the Number One Leader in Decentralized Clinical Trial Products.

The Everest Group is a prestigious “firm focused exclusively on IT, business process, and engineering services.” The firm helps industry leaders gain a “depth of expertise that our clients find invaluable when making critical, strategic decisions related to their use and delivery of sourcing services.” 

Their PEAK Matrix is an independent, objective, data-driven assessment of key service and technology providers based on overall capability and market impact. Thus, we’re humbled that Medable was positioned highest in the leaders quadrant with top scores for both vision and capability as well as market impact. 

The group ranked Medable alongside 14 other companies that specialize in providing decentralized clinical trials. With the recent rise of decentralized clinical trials (DCTs) the market has experienced rapid growth, with hundreds of companies now expanding their capabilities to adjust for the industry’s seismic shift towards patient-centric trials. 

Medable was selected as the leader as a result of our market impact, as well as our vision and capabilities. As the leader in DCT, our company stands out based on five key factors: 

  1. A comprehensive suite of decentralized product capabilities including: eConsent, wearables, BYOD, RPM, medication adherence, televisit, and eCOA/ePRO.
  2. A flexible and extensible platform that supports DCT workflows such as: screening, recruitment, home health and patient engagement.
  3. DCT system that effortlessly scales and integrates with any eClinical platform.
  4. Expertise in human-centered design to enable faster cures and better patient outcomes.
  5. Motivated by the vision and mission of a company founded and run by a physician.

While we’re honored to be ranked number one among our peers, we’re more excited about what it means for our mission of making clinical research more accessible and inclusive for the world’s populations. 

If you’re curious as to what Medable can do for your trials, click here to set up some one-on-one time with a Medable DCT subject matter expert. 

If you would like to access the full report from The Everest Group: click here.

Dan Horsey

Written by Dan Horsey

Dan joins the Marketing team at Medable. Previously, Dan was a Content Manager at Signant Health and a Marketing Manager at IQVIA. He got his start in healthcare marketing in 2014, working with Pharmacy Benefits Managers in the managed Medicare and Medicaid spaces, and has been writing in healthcare capacities for over 10 years. Dan has extensive experience in creating both long and short forms of content across a wide variety of mediums. He earned his Bachelor of Arts in Communications from West Chester University in 2009. In his spare time, Dan composes music as a hobby and plays guitar for a Philadelphia based hardcore band.

Featured